$5.85
0.68% yesterday
Nasdaq, Sep 27, 10:09 pm CET
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock price

$5.85
-0.38 6.10% 1M
-3.65 38.42% 6M
+2.19 59.84% YTD
+2.33 66.19% 1Y
-30.45 83.88% 3Y
-0.28 4.60% 5Y
-21.09 78.29% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.04 0.68%
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Key metrics

Market capitalization $165.88m
Enterprise Value $-53.00m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.73
P/B ratio (TTM) P/B ratio 2.10
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-90.48m
Free Cash Flow (TTM) Free Cash Flow $-72.84m
Cash position $243.13m
EPS (TTM) EPS $-2.26
P/E forward negative
Short interest 12.18%
Show more

Is Mind Medicine Inc - Ordinary Shares (Sub Voting) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

Buy
100%

Financial data from Mind Medicine Inc - Ordinary Shares (Sub Voting)

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
- -
-
100%
- Direct Costs 2.12 2.12
34% 34%
-
-2.12 -2.12
34% 34%
-
- Selling and Administrative Expenses 37 37
11% 11%
-
- Research and Development Expense 49 49
20% 20%
-
-88 -88
14% 14%
-
- Depreciation and Amortization 2.12 2.12
34% 34%
-
EBIT (Operating Income) EBIT -90 -90
12% 12%
-
Net Profit -102 -102
35% 35%
-

In millions USD.

Don't miss a Thing! We will send you all news about Mind Medicine Inc - Ordinary Shares (Sub Voting) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock News

Neutral
Business Wire
18 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 70,000 common shares of the Company (th...
Neutral
Business Wire
24 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences: H.C. Wainwright 26th Annual Global Investment Conference Format: P...
Neutral
Seeking Alpha
about one month ago
Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and MindMed despite setbacks.
More Mind Medicine Inc - Ordinary Shares (Sub Voting) News

Company Profile

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.

Head office Canada
CEO Robert Barrow
Employees 57
Founded 2019
Website www.mindmed.co

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today